Spinal magnetic resonance imaging with reduced specific absorption rate in patients harbouring a spinal cord stimulation device - A single-centre prospective study analysing safety, tolerability and image quality by Mutter, U M et al.
1 
 
Spinal magnetic resonance imaging with reduced specific absorption rate in 
patients harbouring a spinal cord stimulation device -  
A single centre prospective study analysing safety, tolerability and image 
quality 
 
 
 
Urs M. Mutter1,2,*, David Bellut2,3,*, François Porchet2, Bernhard Schuknecht4,+ 
 
 
1Neuro- und Wirbelsäulenzentrum, Hirslanden Klinik St. Anna, Lucerne 
2Spine Center, Schulthess Clinic, Zurich, Switzerland 
3Department of Neurosurgery, University Hospital of Zurich, Switzerland 
4MRI Institute, Zurich Switzerland 
 
 
No disclosure. No conflict of interest. 
 
 
*Authors contributed equally 
+Corresponding author: Dr. med. D. Bellut 
  Department of Neurosurgery, University Hospital of Zurich 
  dbellut@gmail.com 
  
2 
 
1. Abstract 
1.1. Background: 
Spinal Cord Stimulation (SCS) is an accepted treatment in patients with Failed Back 
Surgery (FBS), Complex Regional Pain Syndrome (CRPS) and persistent radicular 
pain following surgery. In order to avoid patient hazards or device malfunction 
manufacturers advise to abstain from magnetic resonance imaging (MRI) in patients 
with implanted electrodes or pulse generators. 
1.2 Methods: 
In a prospective study 13 patients harbouring an implanted Medtronic Spinal Cord 
Stimulation (SCS) device underwent MRI (1.5T) of the lumbar (n = 13), the cervical 
(n=2) or the thoracic spine (n=1) following the development of new spinal symptoms. 
An adapted MRI protocol was used limiting the transmitted energy and specific 
absorption rate.  
Tolerability and safety were assessed by means of a standardized patient evaluation 
form documenting pain on a visual analogue scale (0-10), neurologic deficit and 
discomfort during the scan. In addition, overall satisfaction with the examination 
procedure was rated on a Likert scale (1-5). Image quality was rated independently 
and blinded to the presence of a SCS device by the radiologist and the surgeon as 
equivalent, superior or inferior compared to the standard spine MRI examination. 
1.3 Results: 
None of the 13 patients investigated by the modified spinal MRI protocol experienced 
new neurological deficits, worsening of symptoms or a defect/malfunction of the 
implant device. Three patients (23.1%) reported transient warm sensation in the 
location of the electrode and in one case intermittent slight tingling in the lower 
extremities. Overall satisfaction with the examination was 1.13±0.34 according to 
Likert scale (1-5). The image quality was rated - not statistically significant - slightly 
inferior to standard lumbar spine imaging (0.82±0.54) with a kappa value of 0.68 
between the two investigators. MRI examinations detected relevant and new lesions 
in 9 (69.2%) patients which affected treatment in 8 (61.5%) individuals. 
1.4. Conclusion: 
Using a protocol with a reduced specific energy absorption rate, spinal MRI 
examinations in patients with SCS can be considered safe. The current view that 
neurostimulators are a general contraindication to MR examinations has to be 
reconsidered in patients with new or progressive spinal symptoms. 
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2. Introduction: 
Spinal Cord Stimulation was introduced as a new treatment for chronic pain of spinal 
origin in 1967 when Shealy implanted a dorsal column stimulator in a patient with 
pain due to cancer [20]. The principle of the technique is to inhibit afferent nerve fibre 
activation due to the gate control therapy [15]. SCS has been established as an 
accepted treatment in patients with Failed Back Surgery (FBS) [17, 22], Complex 
Regional Pain Syndrome (CRPS) [2, 10] , persistent radicular pain following surgery 
and  peripheral ischemic limb pain [1, 3, 4, 8, 11] with a considerable number of 
patients having undergone implantation of Spinal Cord Stimulators (SCS) [7]. 
Manufacturer of SCS and the health administration advise not to perform MRI in 
patients with implanted electrodes or pulse generators implanted [13, 14, 24]. In case 
of new symptoms or neurologic deficits alternative diagnostic techniques such as CT, 
myelography or CT myelography harbour the disadvantage of being more invasive 
and less accurate of particularly following previous  spine surgeries. 
Only few studies investigated the use of spinal MRI in patients with SCS or 
intrathecal pump system [5, 6, 9, 12, 16, 23] demonstrating feasibility and safety but 
higher patient numbers or effects of implanted SCS on image quality has not been 
studied. Hazards may arise from the static magnetic field that may exert forces on the 
implanted devices. The pulsed gradient magnetic fields may cause thermal tissue 
damage and malfunction of the device. 
Despite recent observations stating the safety under particular precautions safety 
warnings of the manufacturers and the national health administrations [13, 14, 24] 
refrain most physicians from referring patients with implanted SCS to MRi 
examinations and radiology departments – considering the SCS an absolute 
contraindication do not accept these patients for MRI investigations. 
Based on previous observations of safety of the spinal MRI (13-15) the objective of 
the present study was to evaluate the safety and tolerability of a specifically adapted 
MRI protocol in patients harbouring an implanted SCS device in the clinical setting of 
new symptoms. A further objective was to assess the clinical consequences, and the 
image quality of these MRI studies 
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3. Methods: 
3.1. Study design: 
Following the development of new spinal symptoms 13 patients with implanted 
Medtronic SCS devices (all IPG placed at the buttocks) were prospectively 
investigated by MRI of the lumbar (n = 13), cervical (n=2) or the thoracic spine (n=1) 
using a 1.5T Siemens Magnetom Aera MRI scanner Institutional approval of this 
study for the study and consent had been obtained in every patient. In case of 
neurological deficits or non-conclusive previous CT studies MRI was indicated and 
performed using a specific adapted MR protocol. The Internal Pulse generator (IPG) 
of the SCS device had been deactivated before the examination. Following the MRI 
the patients completed questionnaires for evaluation of the procedure and the SCS 
was activated again by a check of the program functions by the manufacturer`s 
technician. A clinical control was conducted by the same spine surgeon. The image 
quality was compared to the routine spinal MRI protocol by a Neuroradiologist and a 
Surgeon. 
 
 
3.2. Imaging studies: 
Patients were examined in a single radiological centre (Neuroradiology Section, MRI 
Institute Zurich Switzerland) on a 1.5T Magnetom Aera MR scanner Siemens 
Healthcare, Erlangen, Germany 
 
The adapted protocol limited the specific absorption rate (SAR) of transmitted energy 
to 14-37% in the exposed body region in comparison to 50-79% applied by the 
normal spine MR protocol. The specific absorption rate is the energy being absorbed 
by the body. It is measured in Watts per kilogram and used for various devices 
emitting radiofrequencies. For example, for mobile phones there is a maximum SAR 
of 1.6 W/kg in the USA and 2.0 W/kg in the European Union. The protocol comprised 
the sequences and parameters shown in table 5. No fat saturation pulse was applied; 
the positioning mode was put on “reference” instead of “isocentre”. 
 
3.3. Evaluation of tolerability of MRI examination 
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Tolerability and safety were assessed immediately after the examination by means of 
a questionnaire and a standardized patient evaluation form documenting pain on a 
visual analogue scale (0-10), neurologic deficit and discomfort during and right after 
the MR examination. In addition, overall satisfaction with the examination procedure 
was rated on a Likert scale (1-5). Image quality was rated independently by the 
radiologist and the surgeon as equivalent, superior or inferior compared to a routine 
spine MR examination of standard quality. 
 
4. Results: 
4.1. General patients’ data: (Table 1) 
The thirteen patients underwent a mean 2.67 (range: 0-6) operations of the lumbar or 
cervical spine or the upper or lower extremity before SCS implantation due to 
persisting neuropathic pain. These included discectomy for herniated disc, lumbar 
interlaminar decompression spinal canal stenosis and stabilization and fusion for 
degenerative disc disease and severe spondylarthritis. 11 patients underwent SCS 
implantation at the lower thoracic spine for symptoms of lumbar spine origin, one 
patient for treatment of neuropathic pain due to repeat foot surgery and one patient 
after various carpal tunnel surgeries. There were 9 (69.2%) female and 4 (30.7%) 
male patients with a mean age of 56.46±12.79 years at time of the MRI examination 
for the entire series.  
 
4.2. Tolerability of MRI examination (Table 2): 
The examination was well tolerated by every of the 13 patients. Three patients 
(23.1%) reported transient warm sensation in the location of the electrode and in one 
case intermittent slight tingling in the lower extremities was reported. 
The overall level of discomfort (0-10; 0 – lowest, 10 – highest) was 2.00±2.13 on a 
visual analogue scale and the overall satisfaction with the scan (; 1- highest, 5 - 
lowest) was 1.13±0.34. 
None of the patients developed newly symptoms and there was no stimulator 
dysfunction after the MRI. 
 
4.3. MRI findings and therapeutic consequences (Table 3): 
There were 9 out of 13 patients with new imaging findings. Those included 4 cases 
(23.5%) with high grade spinal canal stenosis, 3 cases (17.6%) with disc herniation 
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and 5 cases (29.4%) of severe single segment degeneration with disc protrusion, 
facet joint arthrosis and osteochondrosis. The imaging studies provided an indication 
for further invasive therapy in 8 patients. Three patients (23.1%) underwent epidural 
or facet joint infiltration, two patients (15.4%) underwent lumbar decompression, two 
patients (15.4%) underwent transpedicular stabilization and fusion (T-LIF) and one 
patient (7.7%) underwent microsurgical discectomy. 
 
4.4. Imaging studies and image quality: 
Image quality was rated by the Neuroradiologist and the Surgeon. Images were rated 
in comparison to standard lumbar spine MR study of normal quality. The different 
sequences of all imaging studies of all patients were rated independently (0 – quality 
inferior-, 1 – quality equal-, 2 – quality superior to standard imaging study. We found 
a – statistically not significant – slightly lower imaging quality compared to the 
standard imaging study. The mean values were 0.80±0.60 for the T2-sagittal 
sequences, 0.96±0.52 for the T2-coronal sequences, 0.77±0.56 for the T2-axial 
sequences and 0.75±0.43 for the T1-sagittal sequences. Overall mean value for 
image quality was 0.82±0.54. The inter-rater agreement calculated by Fleiss method 
showed the following kappa-values: 0.73 for the T2-saggital sequences, 0.62 for the 
T2-coronal sequences, 0.73 for the T2-axial sequences and 0.64 for the T1-sagital 
sequences. Overall inter-rater agreement showed a kappa of 0.68. 
 
5. Discussion: 
The need for high resolution imaging like MRI is rising with an increasing number of 
patients harbouring implanted neurostimulation devices. Many of these patients are 
contained within a long term therapy program which facilitates close surveillance in 
case of a new clinical event necessitating medical or surgical treatment. Until 
recently, MRI studies were considered contraindicated or at least not recommended 
by manufacturers and healthcare administrations [24, 25]. The reasons are the use of 
ferromagnetic materials that might interact with the magnetic field and displacement 
or uncontrolled heating of both the IPG or the electrode that may occur. 
Manufacturer taking efforts in developing devices meeting MRI safety 
recommendations and recently percutaneous leads are on their way into clinical use. 
Nevertheless surgical leads cleared for use in an MRI are still unavailable. 
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Several investigations on the effect of MRI on implant carriers with Deep brain 
stimulation (DBS) or cardiac pacemakers are available. Information on the effect of 
MR on implanted spinal cord stimulator devices is rarely available. A 2002 in vitro 
study by Kainz et al revealed a temperature increase of 2.1 °C (whole body SAR 2 
W/kg) at the tip of the leads using a 1.5 and a 3 Tesla scanner on an ITREL III and 
standard electrodes by Medtronic [9]. Usually a range of 45°C is described to be at 
risk for irreversible damages on tissue of the central nervous system (CNS). Due to 
these minor changes the procedure was considered not to be harmful to the patient. 
Rezai et al. [18] in contrast found a temperature increase of 7.1 °C (whole body SAR 
3.9 W/kg) and up to 25°C at the IPG case.  
In our series only three patients reported a warming sensation at the location of the 
IPG (VAS 3/10 and 5 /10) but no clinical events were reported.  
The devices under investigation are all from one manufacturer (Medtronic). This 
limitation is due to the pre-, peri- and post interventional support needed. The 
products are equipped with an electromagnetic interference circuit protection filtering 
high frequency energy – a so called filtered feed through. The amount of ferrous 
material is reduced to the parts like antenna or recharge coil to minimize the 
magnetic pulling. This reduces the risk of circuit breakage and dislocation. Finally the 
recent generation of neuromodulation devices does not carry magnetic reed switches 
that can be damaged during MRI procedure. While all the neurostimulators on the 
market look similar the safety labelling of one company does not apply for the other 
and other devices are equipped with other safety features. All of the systems still 
have to manage the RF lead heating risk due to the unavoidable unintentional 
antenna that the leads and extensions create. 
Regarding reports of unintentional activation of the system [19, 21] no activation was 
found in our series. One patient reported twitches during the scan but no noticeable 
problems could be detected in the system check. Anecdotic reports of high powered 
stimulation of non deactivated stimulators are available. The recommend is that the 
IPG should be deactivated during the procedure.  
 
Image Quality was comparable and not statistically different from the quality derived 
from an optimized standard spine imaging protocol. The quality of T2 weighted 
sequences which provide the highest diagnostic yield was closer to the quality 
standard protocol than the sagittal T1 weighted sequence. Particular sequences like 
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fat suppressed contrast enhanced T1 weighted series that apply a high specific 
absorption rate have to be avoided. However, these are not a component of the 
standard spine protocol either 
Only few papers are available discussing the use of MRI in patient with implanted 
SCS like the study by De Andres et al [5]. We followed his recommendations 
regarding reduction of specific absorption rate and furthermore aimed to quantify 
patient safety and satisfaction and image quality as described above. 
There are certainly some limitations to the present study. The protocol used is safe, 
and well tolerable at 1.5 Tesla and  provides a good image quality not significantly 
different from the normal MR spine protocol. Special sequences as DTI or 
examinations  within  3 Tesla magnet bore convey higher energy and thus are like 
not safe. Another limitation the current study is the small patient population. 
 
6. Conclusion: 
Using a specifically adapted protocol with a reduced SAR – as presented in the 
protocol MR examinations at 1.5 T filed strength can be considered a safe procedure 
in patients with SCS. The current view that neurostimulators being labelled “not MRI 
compatible” are still a general contraindication to MR examinations therefore should 
be questioned. Evaluation of the SCS function before and after MRI is indispensable 
and further evaluation of other types of IPG and electrodes will increase safety and 
feasibility of the procedure. 
 
 
7. Case report  
 
A forty year old patient with a history of five times surgery for foraminal stenosis and 
spinal canal stenosis of the lumbar segment L2/3 and L3/4 with symptoms of axial 
low back pain and radiculopathy received stabilization and intercorporal fusion L2-4 
as ultimate treatment option. For persisting symptoms he underwent SCS 
implantation. There was a three year course with distinct improvement of symptoms. 
The patient then became symptomatic with right-sided L5 radiculopathy with pain, 
hypaesthesia and motor palsy (M4/5). MRI with special neurostimulator protocol was 
performed and revealed a newly developed disc protrusion L5/S1 with contact to L5 
nerve root. After failure of conservative treatment regarding the motor weakness the 
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patient underwent sequesterectomy L5/S1. Three month follow-up showed good 
outcome with complete regression of radicular symptoms and motor weakness. 
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Figure 1: Sagittal (A), axial (B) and coronal (C) T2-weighted MRI of patient after two 
  level stabilization and fusion and implantation of SCS 
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8. Tables 
 
Number of patients 13 
Number of MRI examinations 17 
Mean patient age [years] 56.46±12.79 
Male / Female patients 9 (69.2%) / 4 (30.7%) 
MRI examination performed CS: 3 / ThS: 1 / LS: 13 
Number of spinal surgeries before SCS implantation 2.67±1.62 
Origin of symptoms  
 - Degenerative spine disease 11 (84.6%%) 
 - Neuropathic pain due to M. Sudeck (LE) 1 (7.7%) 
 - Neuropathic pain due to CTS 1 (7.7%) 
Table 1: General patients’ data (per patient) 
 
Cases of heating of IPG (0-1) 2 (11.8%) 
Cases of heating of electrode (0-1) 1 (5.9%) 
Pts. experiencing dysesthesia (0-1) 5 (29.4%) 
Pts. experiencing pain (0-1) 4 (23.5%) 
Overall level of discomfort (1-10) 2.00±2.13 
Overall level of satisfaction (1-5) 1.13±0.34 
Pts. with dysfunction of SCS after MRI examination 0 (0.0%) 
Table 2: Tolerability of MRI examination (Data per examination) 
 
MRI findings  
 - High grade spinal canal stenosis 4 (23.5%) 
 - Disc herniation 3 (17.6%) 
 - Severe, single segment degeneration 5 (29.4%) 
Therapeutic consequences  
 - Microsurgical discectomy 1 (7.7%) 
 - Microsurgical spinal canal decompression 2 (15.4%) 
 - Stabilization and fusion (T-LIF) 2 (15.4%) 
 - Infiltration (epidural, facet joints) 3 (23.1%) 
Table 3: MRI findings and therapeutic consequences 
 
 Flip angle RFPulse  Gradient mode Turbo factor TR SAR  
Localizer 20deg Low SAR Whisper / 7,3 1% 
T2_tse_sag 120deg Low SAR Whisper 12 4120 14% 
T2_tse_cor 120deg Low SAR Whisper 12 4040 15% 
T2_tse_tra 120deg Low SAR Whisper 15 3200 19% 
T1_tse_sag 150deg Low SAR Whisper 3 677 37% 
Table 5 – Parameters of imaging studies 
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No A S Type of SCS 
Site of 
electrode MRI MRI findings 
Overall 
discomfort 
Overall 
satisfaction 
Therapeutic 
consequences 
1 50 F Prime Advanced Th9/10 LS Facet joint degeneration L5/S1 0 1 Infiltration 
2 44 M Synergy Th9/10 LS Spinal canal stenosis L5/S1 3 1 Lu. decompression 
3 40 M Prime Advanced Th9/10 LS Herniated disc L5/S1 4 2 Lumbar discectomy 
4 45 F Prime Advanced Th9/10 LS Segment degeneration L5/S1 5 2 T-LIF 
5 48 F Restore Ultra Th9/10 LS Adjacent segment degeneration 0 1 Infiltration 
6 45 F Itrel 3 Th9/10 LS;LS No new findings 0;4 1;1 none 
7 75 F Synergy Th9/10 LS No new findings 0 1 none 
8 80 M Prime Advanced Th9/10 LS No new findings 0 1 none 
9 63 F Restore Ultra Th10/11 CS;LS Foraminal stenosis C5, L5 1;4 1;1 Infiltration 
10 66 M Restore Ultra Th10/11 CS;ThS;LS Spinal canal stenosis 0;0;0 1;1;1 Lu. decompression 
11 65 F Restore Ultra Th10/11 LS No new findings 6 1 T-LIF 
12 46 F Restore Ultra Th9/10 LS Herniated disc L4/5 3 1 none 
13 67 F Itrel 3 Th1/2 CS Myelopathy 0 1 none 
Table 4: Patients overview 
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9. Figure and table legends 
 
Table 1:  General patients’ data 
Table 2:  Tolerability of MRI examination 
Table 3: MRI findings and therapeutic consequences 
Table 4: Patients overview 
Figure 1: Sagittal (A), axial (B) and coronal (C) T2-weighted MRI of patient after 
  two level stabilization and fusion and implantation of SCS 
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